August 20, 2020
Webinar
35 U.S.C. § 112 of U.S. patent law outlines several requirements of a U.S. patent, and they are important considerations for drafting and prosecuting a patent application as well as litigating a patent. With the advent of new technologies, we have been faced with new challenges in complying with the long-standing requirements. This is true for Japanese companies involved in the fields of hi-tech and bio-pharm.
This webinar will discuss strategic considerations in complying with Section 112 requirements. We will address a few of the requirements from hi-tech and bio-pharm perspectives.
Topics to be discussed include:
This webinar will be presented in Japanese.
Speakers:
Chiaki Kobayashi
Naoki Yoshida
Time:
10:00 – 11:00 a.m. Japan
antibodies, functional claiming, Japan, patent application, patent application drafting, Written description (35 USC § 112)
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.